Morris Timothy E Insider Trades

Insider Trading History

Track insider trading activity for Morris Timothy E. See latest buy and sell transactions across all companies.

Holdings

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price

Insider Trades History

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price
Aquestive Therapeutics
Aquestive Therapeutics AQST
Director
Holding Value $169k 42,000 shares
Last Trade
Jun 11, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$143k 42,000 shares
$3.41
$4.03
Aquestive Therapeutics
Aquestive Therapeutics AQST
Director
Holding Value $153k 38,000 shares
Last Trade
Jun 20, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$95k 38,000 shares
$2.50
$4.03
DBV Technologies
DBV Technologies DBVT
Director
Holding Value $212k 12,000 shares
Last Trade
Aug 25, 2023 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$179k 12,000 shares
$14.90
$17.70
Aquestive Therapeutics
Aquestive Therapeutics AQST
Director
Holding Value $101k 25,000 shares
Last Trade
Jun 21, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$50.5k 25,000 shares
$2.02
$4.03
Aquestive Therapeutics
Aquestive Therapeutics AQST
Director
Holding Value $115k 28,500 shares
Last Trade
Aug 16, 2022 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$42.8k 28,500 shares
$1.50
$4.03
Humanigen
Humanigen HGEN
Director, COO And CFO
Holding Value $120 600,360 shares
Last Trade
Jul 27, 2022 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$228k 600,360 shares
$0.38
$0.00
Humanigen
Humanigen HGEN
COO And CFO
Holding Value $12 59,841 shares
Last Trade
Jan 12, 2022 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$179k 59,841 shares
$2.99
$0.00
Humanigen
Humanigen HGEN
COO And CFO
Holding Value $10.2 51,000 shares
Last Trade
Dec 31, 2021 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$190k 51,000 shares
$3.72
$0.00
DBV Technologies
DBV Technologies DBVT
Director
Holding Value $121k 6,837 shares
Last Trade
Jun 10, 2021 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$407k 6,837 shares
$59.60
$17.70
Humanigen
Humanigen HGEN
COO And CFO
Holding Value $30.3 151,316 shares
Last Trade
Sep 18, 2020 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$1.46M 151,316 shares
$9.65
$0.00
Iovance Biotherapeutics
Iovance Biotherapeutics IOVA
Chief Financial Officer
Holding Value $379k 100,000 shares
Last Trade
Mar 04, 2019 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$1.13M 100,000 shares
$11.26
$3.79
Humanigen
Humanigen HGEN
Director
Holding Value $143 715,877 shares
Last Trade
Mar 09, 2018 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$19M 804,112 shares
$23.59
$0.00
Iovance Biotherapeutics
Iovance Biotherapeutics IOVA
Chief Financial Officer
Holding Value $948k 250,000 shares
Last Trade
Aug 14, 2017 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$1.26M 250,000 shares
$5.05
$3.79
Acelrx Pharmaceuticals
Acelrx Pharmaceuticals ACRX
Chief Financial Officer
Holding Value $96.8k 112,500 shares
Last Trade
Feb 07, 2017 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$6.75M 112,500 shares
$60.00
$0.86
Humanigen
Humanigen HGEN
Director
Holding Value $20 100,000 shares
Last Trade
Sep 13, 2016 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$2.36M 100,000 shares
$23.59
$0.00
Acelrx Pharmaceuticals
Acelrx Pharmaceuticals ACRX
Chief Financial Officer
Holding Value $95k 110,500 shares
Last Trade
Feb 10, 2016 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$7.51M 110,500 shares
$68.00
$0.86
Acelrx Pharmaceuticals
Acelrx Pharmaceuticals ACRX
Chief Financial Officer
Holding Value $86k 100,000 shares
Last Trade
Apr 29, 2015 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$8.48M 100,000 shares
$84.80
$0.86
Acelrx Pharmaceuticals
Acelrx Pharmaceuticals ACRX
Chief Financial Officer
Holding Value $86k 100,000 shares
Last Trade
Dec 02, 2014 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$13.2M 100,000 shares
$132.00
$0.86
Acelrx Pharmaceuticals
Acelrx Pharmaceuticals ACRX
Chief Financial Officer
Holding Value $172k 200,000 shares
Last Trade
May 07, 2014 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$41.4M 200,000 shares
$206.80
$0.86

See more insider trades for free

Join Stockcircle to see more insider trades and be the first to know about new executive transactions.

Sign Up